Associated Papers
Building individualized medicine: prevention of adverse reactions to warfarin therapy.
Krynetskiy E et al.
The Journal of Pharmacology and Experimental Therapeutics, 2007
VKORC1 gene variations are the major contributors of variation in warfarin dose in Japanese patients.
Obayashi K et al.
Clinical Pharmacology and Therapeutics, 2006
Select a paper to view details